Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
donepezil hydrochloride
Apotex Pty Ltd
Donepezil hydrochloride
Registered
TERRY WHITE CHEMISTS DONEPEZIL TABLETS 1 TERRY WHITE CHEMISTS DONEPEZIL TABLETS _Contains the active ingredient donepezil hydrochloride (as monohydrate) _ CONSUMER MEDICINE INFORMATION _FOR A COPY OF A LARGE PRINT LEAFLET, PH: 1800 195 055 _ WHAT IS IN THIS LEAFLET READ THIS LEAFLET CAREFULLY BEFORE TAKING YOUR MEDICINE. This leaflet answers some common questions about donepezil. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the last page. More recent information on this medicine may be available. ASK YOUR DOCTOR OR PHARMACIST: • if there is anything you do not understand in this leaflet, • if you are worried about taking your medicine, or • to obtain the most up-to-date information. All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. Pharmaceutical companies cannot give you medical advice or an individual diagnosis. Keep this leaflet with your medicine. You may want to read it again. WHAT THIS MEDICINE IS USED FOR The name of your medicine is Terry White Chemists Donepezil. It contains the active ingredient donepezil hydrochloride (as monohydrate). It is used to treat mild, moderate and severe Alzheimer's disease, also called dementia of the Alzheimer's type. This medicine will not cure this disease, but it should help your memory and improve your ability to think more clearly. Ask your doctor if you have any questions about why this medicine has been prescribed for you. Your doctor may have prescribed this medicine for another reason. This medicine is available only with a doctor's prescription. There is no evidence that this medicine is addictive. _HOW IT WORKS _ This medicine belongs to a group of medicines called acetylcholinesterase inhibitors. They are thought to work by increasing the level of a chemical called acetylcholine in the brain. _USE IN CHILDREN Read the complete document
1 AUSTRALIAN PRODUCT INFORMATION TERRY WHITE CHEMISTS DONEPEZIL (DONEPEZIL HYDROCHLORIDE MONOHYDRATE) TABLETS 1 NAME OF THE MEDICINE Donepezil hydrochloride monohydrate. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg or 10 mg donepezil hydrochloride (as monohydrate) as the active ingredient, equivalent to 4.56 mg or 9.12 mg donepezil free base, respectively. EXCIPIENTS WITH KNOWN EFFECT Lactose monohydrate For the full list of excipients see section 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM 5 MG TABLETS: White to off-white, circular, biconvex, film coated tablets embossed with “C” on one side and “7” on the other side. 10 MG TABLETS: Yellow, circular, biconvex, film coated tablets embossed with “C” on one side and “6” on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Donepezil hydrochloride is indicated for the treatment of mild, moderate and severe Alzheimer’s disease. 4.2 DOSE AND METHOD OF ADMINISTRATION Terry White Chemists Donepezil tablets are intended for oral administration. DOSAGE ADULTS / ELDERLY Treatment should be initiated and supervised by a doctor experienced in the diagnosis and treatment of Alzheimer’s Dementia. Individual response to donepezil hydrochloride cannot be predicted. Treatment should be continued for as long as a therapeutic benefit for the patient exists. Discontinuation of therapy should be considered where there is no longer evidence of a therapeutic effect, which should be assessed by periodic evaluations by the physician using input from the patient and caregiver. The dosages of donepezil hydrochloride shown to be effective in controlled clinical trials are 5 mg and 10 mg administered once daily. Although there is no statistically significant evidence that a greater treatment effect is obtained from the use of the 10 mg dose, there is a suggestion, based on analysis of group data, that some additional benefits may accrue to some patients from the use of the higher dose. 2 Treatment is initiated at 5 mg/day (once-a- Read the complete document